These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17724372)
1. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Hernandez W; Grenade C; Santos ER; Bonilla C; Ahaghotu C; Kittles RA Carcinogenesis; 2007 Oct; 28(10):2154-9. PubMed ID: 17724372 [TBL] [Abstract][Full Text] [Related]
2. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3. Safarinejad MR; Shafiei N; Safarinejad S Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221 [TBL] [Abstract][Full Text] [Related]
4. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. Friedrichsen DM; Hawley S; Shu J; Humphrey M; Sabacan L; Iwasaki L; Etzioni R; Ostrander EA; Stanford JL Prostate; 2005 Sep; 65(1):44-51. PubMed ID: 15800934 [TBL] [Abstract][Full Text] [Related]
5. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. D'Aloisio AA; Schroeder JC; North KE; Poole C; West SL; Travlos GS; Baird DD Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):954-66. PubMed ID: 19240240 [TBL] [Abstract][Full Text] [Related]
6. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Keku TO; Vidal A; Oliver S; Hoyo C; Hall IJ; Omofoye O; McDoom M; Worley K; Galanko J; Sandler RS; Millikan R Cancer Causes Control; 2012 Jul; 23(7):1127-38. PubMed ID: 22565227 [TBL] [Abstract][Full Text] [Related]
7. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Gu F; Schumacher FR; Canzian F; Allen NE; Albanes D; Berg CD; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Buring JE; Chabbert-Buffet N; Chanock SJ; Clavel-Chapelon F; Dumeaux V; Gaziano JM; Giovannucci EL; Haiman CA; Hankinson SE; Hayes RB; Henderson BE; Hunter DJ; Hoover RN; Johansson M; Key TJ; Khaw KT; Kolonel LN; Lagiou P; Lee IM; LeMarchand L; Lund E; Ma J; Onland-Moret NC; Overvad K; Rodriguez L; Sacerdote C; Sánchez MJ; Stampfer MJ; Stattin P; Stram DO; Thomas G; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Zhang SM; Kaaks R; Riboli E; Ziegler RG; Kraft P Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2877-87. PubMed ID: 20810604 [TBL] [Abstract][Full Text] [Related]
8. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Platz EA; Pollak MN; Rimm EB; Majeed N; Tao Y; Willett WC; Giovannucci E Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1107-10. PubMed ID: 10613344 [TBL] [Abstract][Full Text] [Related]
9. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors. Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1394-401. PubMed ID: 15941947 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor. Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371 [TBL] [Abstract][Full Text] [Related]
11. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS; PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer. Winter DL; Hanlon AL; Raysor SL; Watkins-Bruner D; Pinover WH; Hanks GE; Tricoli JV Urology; 2001 Oct; 58(4):614-8. PubMed ID: 11597555 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population. Qian J; Zhou H; Chen J; Ding Q; Cao Q; Qin C; Shao P; Li P; Cai H; Meng X; Ju X; Wang M; Zhang Z; Li J; Hua L; Yin C PLoS One; 2014; 9(2):e85609. PubMed ID: 24586243 [TBL] [Abstract][Full Text] [Related]
14. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. Wolk A; Mantzoros CS; Andersson SO; Bergström R; Signorello LB; Lagiou P; Adami HO; Trichopoulos D J Natl Cancer Inst; 1998 Jun; 90(12):911-5. PubMed ID: 9637140 [TBL] [Abstract][Full Text] [Related]
16. Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women. Qian B; Zheng H; Yu H; Chen K Breast Cancer Res Treat; 2011 Nov; 130(1):217-26. PubMed ID: 21562710 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindström S; Albanes D; Ziegler RG; McCullough ML; Siddiq A; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock SJ; Crawford ED; Diver WR; Gapstur SM; Giovannucci E; Gu F; Haiman CA; Hayes RB; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Kraft P; Le Marchand L; Overvad K; Polidoro S; Riboli E; Schumacher FR; Stevens VL; Trichopoulos D; Virtamo J; Willett WC; Key TJ Int J Cancer; 2013 Jul; 133(2):495-504. PubMed ID: 23341348 [TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population. Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087 [TBL] [Abstract][Full Text] [Related]
19. Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk. Tsai CW; Chang WS; Xu Y; Huang M; Bau DT; Gu J Mol Carcinog; 2021 Nov; 60(11):726-733. PubMed ID: 34293213 [TBL] [Abstract][Full Text] [Related]
20. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene. Safarinejad MR; Shafiei N; Safarinejad SH Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]